RSV is a common respiratory virus that can become serious for infants, older adults, and people with certain underlying health conditions. Vaccination can help lower the risk of severe disease and hospitalization.
RSV immunization is recommended for:
- Infants younger than 8 months whose mothers were not vaccinated during pregnancy
- Certain children ages 8–19 months who are at higher risk for severe RSV disease
- Adults ages 50–74 years with health conditions that increase their risk for severe RSV illness
- All adults ages 75 years and older
Unlike the flu vaccine, the RSV vaccine is not given every year. For adults who are eligible, the current recommendation is a single dose. Experts continue to study how long protection lasts and whether additional doses may be needed in the future.
Guidance and recommendations come from these leading medical organizations:
- AAFP — American Academy of Family Physicians
- AAP — American Academy of Pediatrics
- ACOG — American College of Obstetricians and Gynecologists
- IDSA — Infectious Diseases Society of America
